Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-01-01 @ 7:35 AM
Study NCT ID:
NCT01570868
Status:
TERMINATED
Last Update Posted:
2025-12-08
First Post:
2012-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-02
First Submit QC Date:
None
Study First Post Date:
2012-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-26
Results First Submit QC Date:
None
Results First Post Date:
2019-09-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-01
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED